Searched for
HCV
AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...- India auto wholesales jump in March; PVs, tractors lead the chargeVehicle sales in March 2026 showed strong performance. Passenger vehicles and tractors led the growth. Two-wheelers and commercial vehicles...
- Montra Electric to unveil eHCV commercial manufacturing plant in ManesarMurugappa Group's Montra Electric HCV (IPL Tech) is set to launch its advanced electric heavy commercial vehicle manufacturing facility in ...
- Industry smells a jackpot as India's truck fleet hits 10-yr highIndia's aging fleet of medium and heavy commercial vehicles is poised for a significant replacement surge, driven by trucks reaching a reco...
- Ashok Leyland shares jump 3% after reporting February sales dataAshok Leyland shares increased by 3.3% as the company reported February 2025 vehicle sales at 15,879 units, a 4% decrease compared to the p...
- Ashok Leyland shares jump 3% as December sales grow 5% YoYAshok Leyland shares rose 3% after posting a 5% YoY increase in December sales, though cumulative sales fell 2%. M&HCV segment saw growth, ...
- Ashok Leyland total vehicle sales grow 23 per cent in JanuaryDomestic sales (M&HCV and LCV) in the reporting month were recorded at 16,198 units, a growth of 27 per cent over 12,709 units in January 2...
- Ashok Leyland reports 125 per cent growth in June salesThe total M&HCV sales, including exports, rose 238 per cent at 9,354 units in June 2022 as against 2,764 units in June 2021.The LCV total s...
- There is a lot of growth waiting to happen in LCV: Ravi Pisharody, Tata Motors"In most markets like India the LCV to HCV ratios 3:1, 4:1 and even 6:1, here we had reached a level of 2:1 somewhere around in 2012."
- Buy Tata Motors, target Rs 536: Vinod NairTata Motors is India's largest CV manufacturer with 52 per cent market share in M&HCV segment. The domestic M&HCV segment is going at a fas...
- Financing defaults in SCV front due to two and a half years of recession: Ravi Pisharody, Tata Motors"There are couple of things which are quite favourable from the point of 16-17 years."
- Cipla partners with non-profit body FIND to increase detection of Hepatitis CThe organisation works on accelerating development and delivery of affordable diagnostic tests for poverty-related diseases.
- NGO FIND, Cipla tie-up for Hepatitis C treatment in India"Partnering with leading doctors in the field of liver disease, Cipla has been able to provide treatment to thousands of patients over the ...
- Combined HIV, Hepatitis C vaccination in the offingScientists have for the first time found that it is possible to generate simultaneous immune response against Hepatitis C virus and HIV, ra...
- Hepatitis C may increase cancer riskResearchers found that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohor...
- Hepatitis C free India achievable: Expert"India is facing a serious threat from Hepatitis C virus (HCV). It is, however, going to take a lot more than low-cost drugs to get patient...
- M&HCV segment likely to grow by 20% over the next 2-4 years: Frost & SullivanDemand for Commercial Vehicle in the domestic market is expected to increase to one million units a year, mainly driven by Medium and Heavy...
- Stock pick: Better days ahead for Wabco India, expected revival in HCV segment to benefit itIt could maintain high growth rates despite the fact that the medium & heavy commercial vehicles (M&HCV) segment was experiencing a down cy...
- ET Review: Panasonic’s HC-V 500MPanasonic’s HC-V 500M full HD camera might fit the bill for someone looking for a small, unobtrusive , easy-to-use and yet highly capable d...
- HC grants protection to J Mitra's diagnostic kitThe Delhi High Court has granted protection to J Mitra Company's HCV TRI-DOT, a device used in detection of Hepatitis C, while refraining S...
Load More
